Edition:
United States

People: Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

66.36USD
3:06pm EDT
Change (% chg)

$1.24 (+1.90%)
Prev Close
$65.12
Open
$65.17
Day's High
$66.67
Day's Low
$64.75
Volume
50,634
Avg. Vol
153,554
52-wk High
$91.03
52-wk Low
$31.19

Parker, Geoffrey 

Mr. Geoffrey M. Parker is Independent Director of the Company. Mr. Parker previously served as the Chief Financial Officer of Anacor Pharmaceuticals, Inc. from September 2010 to May 2015 and as a consultant to Anacor from June 2015 to November 2015. Mr. Parker previously served as the Vice President, Managing Director and Partner at the global investment banking and securities firm Goldman, Sachs & Co., leading their west coast Healthcare Investment Banking practice from April 1997 to April 2009. Mr. Parker is a director of ChemoCentryx, Inc. and Perrigo Company plc. Mr. Parker holds an A.B. from Dartmouth College in Engineering Sciences and Economics and an M.B.A. from the Stanford Graduate School of Business.

Basic Compensation

Total Annual Compensation, USD 56,750
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 132,727
Fiscal Year Total, USD 189,477

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kimberly Popovits

4,117,300

Gordon Cole

1,606,770

Steven Shak

1,418,200

Phillip Febbo

--

Laura Kammeyer

--

Frederic Pla

1,588,330
As Of  30 Dec 2017